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The ESET (also called SETDB1) protein contains an N-terminal tudor domain that mediates protein–
protein interactions and a C-terminal SET domain that catalyzes methylation of histone H3 at lysine 9.
We report here that ESET protein is transiently upregulated in prehypertrophic chondrocytes in newborn
mice. To investigate the in vivo effects of ESET on chondrocyte differentiation, we generated conditional
knockout mice to speciﬁcally eliminate the catalytic SET domain of ESET protein only in mesenchymal
cells. Such deletion of the ESET gene caused acceleration of chondrocyte hypertrophy in both embryos
and young animals, depleting chondrocytes that are otherwise available to form epiphyseal plates for
endochondral bone growth. ESET-deﬁcient mice are thus characterized by defective long bone growth
and trabecular bone formation. To understand the underlying mechanism for ESET regulation of
chondrocytes, we carried out co-expression experiments and found that ESET associates with histone
deacetylase 4 to bind and inhibit the activity of Runx2, a hypertrophy-promoting transcription factor.
Repression of Runx2-mediated gene transactivation by ESET is dependent on its H3–K9 methyltransfer-
ase activity as well as its associated histone deacetylase activity. In addition, knockout of ESET is
associated with repression of Indian hedgehog gene in pre- and early hypertrophic chondrocytes.
Together, these results provide clear evidence that ESET controls hypertrophic differentiation of growth
plate chondrocytes and endochondral ossiﬁcation during embryogenesis and postnatal development.
Published by Elsevier Inc.Introduction
Methylation of histone H3 at lysine 9 (H3–K9) can be found in
both euchromatic and heterochromatic regions within the mam-
malian genome, and is one of the most important epigenetic
markers for gene repression. At the present time, four prominent
H3–K9-speciﬁc histone methyltransferases (Suv39h, G9a, GLP and
ESET) have been intensively studied, all of which contain a
conserved SET domain that is responsible for their methyltrans-
ferase activities (Kouzarides, 2007). Mice harboring simultaneous
disruption of both Suv39h1 and Suv39h2 are viable but exhibited
chromosome missegregation and mitotic defects (Peters et al.,
2001). Knockout of the G9a or GLP gene in mice inducedInc.
partment of Orthopedics and
eattle, WA 98108,embryonic lethality around embryonic day 9.5 (E9.5) due to severe
growth defects (Tachibana et al., 2002, 2005). Conventional dele-
tion of the ESET gene also resulted in embryonic lethality around
the stage of implantation (Dodge et al., 2004).
To investigate the effects of H3–K9 methyltransferases on later
stages of embryogenesis and postnatal development, we have focused
on the ESET protein that was originally identiﬁed by our group as an
ERG-interacting protein with a SET domain. ESET protein is encoded
by a single copy gene that is evolutionarily conserved. Mouse ESET
gene is 36 kb in length and consists of 22 exons, giving rise to a full-
length ESET protein with 1307 amino acids. Other minor ESET splice
variants lacking the SET domain are also known to exist in certain cell
types (Blackburn et al., 2003). ESET protein has been proposed to
repress gene expression through the recruitment of other enzymes
such as DNA methyltransferase DNMT3A and histone deacetylases
HDAC1/HDAC2 (Li et al., 2006; Yang et al., 2003). In this study we
initially observed transient upregulation of ESET protein in prehyper-
trophic chondrocytes, we therefore speculated that the H3–K9methyl-
transferase activity of ESET might be involved in the control of
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ated mice with conditional deletion of the SET domain from the ESET
gene in mesenchymal cells which can give rise to chondrocytes during
skeletal development. Phenotype analysis of these ESET knockout
mice reveals that ESET protein indeed plays an essential role during
hypertrophic differentiation of chondrocytes and development of the
epiphyseal plate. Though H3–K9 methyltransferases are increasingly
recognized as critical regulators of embryonic stem cells and are
essential to early stages of embryogenesis, it is less understood how
they exert their inﬂuence on speciﬁc tissues during later stages of
embryogenesis and postnatal development. This study therefore
provides in vivo evidence that proper differentiation of certain tissue
(cartilage) is controlled by a speciﬁc H3–K9 methyltransferase (ESET)
through recruitment of additional histone enzymes to ﬁne tune gene
expression.Materials and methods
Generation of conditional ESET-null mice
Mice harboring the ESET(exons 15&16)Flox allele were kindly
provided by Dr. Y. Shinkai (Matsui et al., 2010). Prx1-Cre mice were
obtained from the Jackson Laboratory. Newborn pups were kept at
ﬁve or fewer per litter (through the removal of wild-type or
heterozygous littermates) to increase the survival of (exons
15&16)CKO/CKO mutants that are weaker at birth. Weaned mutant
mice were fed with DietGel soft maintenance diet to ensure
adequate intake of food and water. Identiﬁcation of the ﬂoxed
ESET allele was determined by PCR ampliﬁcation of tail DNA using
primers KG-U8: 5′-ACC AGT TCA GTG TGG CGT-3′ and KG-D15:
5′-TTT CTT TGC CTT TGA GAT GGA-3′. When separated on a 1.5%
agarose gel, the (exons 15&16)Flox allele gives rise to a band
(756 bp) that is longer than the band (630 bp) from wild-type
ESET allele. Existence of Prx1-Cre in the genome was conﬁrmed by
PCR detection of a 465 bp band using primers Cre-U1: 5′-GCG GTC
TGG CAG TAA AAA CTA TC-3′ and Cre-D2: 5′-TAT TCG GAT CAT CAG
CTA CAC CAG AG-3′. Prior to the study, all experiments were
reviewed and approved by the Institutional Animal Care and Use
Committee at the VA Puget Sound Health Care System.
Differential staining of cartilage and bone
Embryonic or newborn mice were skinned, eviscerated, and
ﬁxed in 95% ethanol for 5 days, then placed in acetone for 4 days to
remove fat and to keep the specimen ﬁrm. Skeletal preparations
were then stained using alcian blue and alizarin red as previously
described (McLeod, 1980). Soft tissue was removed by incubation
in 1% KOH for one day, followed by frequent changes with a 20%
glycerol–1% KOH solution, and ﬁnally checked with a dissecting
microscope.
Histological analysis and immunohistostaining
After evisceration, Embryonic or newborn mice were ﬁxed in
4% phosphate-buffered paraformaldehyde at 4 1C for 24 h, decalciﬁed
in 14% EDTA at pH 7.2. Samples were then soaked in 10% sucrose in
PBS for 8 h, transferred to 30% sucrose in PBS at 4 1C under constant
agitation overnight. The tissues were then embedded in OCT com-
pound on dry ice, cut as 10–18 mm thick frozen sections using a
cryostat. The sections were dried for 2 h on a slide warmer at 37 1C,
then stained with the modiﬁed Harris hematoxylin solution (Sigma
cat# HHS32)-eosin Y-phloxine B solution, or with a Safranin O stain kit
from IHC World.
In antigen retrieval for type X collagen, tissue sections were
ﬁrst treated in 0.2 M boric acid (pH 7.0) at 60 1C overnight, washedwith 0.25% Triton X-100 in PBS, allowed to air dry, then continued
with hyaluronidase (2 mg/ml, Sigma) at room temperature for
30 min. After stoppage of the enzymatic digestion with normal
goat serum, tissue sections were blocked in 0.25% Triton X-100, 2%
BSA, 2% normal goat serum for 2 h and incubated with a rabbit
antibody against type X collagen (Hjorten et al., 2007) at 1: 200
dilution. In antigen retrieval for osteocalcin, tissue sections were
incubated with proteinase K (40 μg/ml, Sigma) at room tempera-
ture for 1 h, and the protein was detected with a rabbit polyclonal
anti-osteocalcin from Abcam (catlog # ab93876) at 1: 200 dilution.
For detection of ESET protein, a rabbit polyclonal anti-ESET anti-
body (against residues 1–167 of mouse ESET) from Millipore
(catalog # 07-378) was used at a 1:100 dilution. For detection of
apoptotic cells, a rabbit polyclonal anti-active Caspase 3 antibody
from Abcam (catalog #ab13847) was used at 1:100 dilution. For
detection of Indian hedgehog protein, a rabbit polyclonal anti-Ihh
from Santa Cruz Biotechnology (catalog # sc-13088) was used at
1:50 dilution. Tissue sections were incubated with antibodies
overnight, washed in PBS, followed by a Cy3-conjugated goat
anti-rabbit IgG from Jackson ImmunoResearch Laboratories at a
1:200 dilution for one hr at room temperature. Slides were then
washed multiple times in PBS with 0.25% Triton X-100, and
mounted with Vectorshield mounting medium with DAPI for
examination under a ﬂuorescence microscope.
Immunoprecipitation and western blotting
1.2107 293 T cells in a 10 cm dish were transfected with 6 μg
pSG5-FL-ESET (Yang et al., 2002) plus 6 μg of pHA-Runx2 (Jensen
et al., 2008) using Lipofectamine 2000 (Invitrogen) according to
the manufacturer's instructions. 48 h after transfection, cells were
lysed in 1 ml low salt lysis buffer (10 mM Tris, pH 7.4, 2.5 mM
MgCl, 50 mM NaCl, 0.5% Triton X-100, 10 mM dithiothreitol)
supplemented with a protease inhibitor cocktail (Sigma). After
sonication, lysate was precleared with 150 μl of Protein A/G Plus
agarose (Santa Cruz Biotechnology) at 4 1C for 2 h and high speed
centrifugation. 0.2 ml Lysate was then mixed with 50 μl of Protein
A/G Plus agarose and incubated with the mouse monoclonal anti-
Flag (M2) from Sigma, the mouse monoclonal anti-HA (F7), anti-
HDAC4 (A-4) or normal mouse IgG from Santa Cruz Biotech
overnight. After 3 washes with the low salt lysis buffer, the
immunoprecipitates were separated by SDS-PAGE, transferred to
a PVDF membrane, blotted with HRP-conjugated goat anti-Flag
and anti-HA antibodies (Sigma), or with the goat anti-HDAC4
(N-18, Santa Cruz Biotech). Protein bands were visualized using
the ECL Plus Western Blotting Detection System (Amersham).
Transfection and luciferase assays
Using the Lipofectamine 2000 method, 500 ng of pOG2-Luc
(Schroeder et al., 2004), 1000 ng of pCMV-HA-Runx2 (Vega et al.,
2004) and 1000 ng of pSG5-FL-ESET plus 25 ng of pRL-SV40 were
transfected into 5105 of COS-7 cells in one well of a 6-well plate.
After incubation for 24 h in DMEM medium with 10% FBS,
trichostatin A was added to a ﬁnal concentration of 100 ng/ml.
24 h Later, the cells were washed once with PBS and lysed with
0.5 ml passive lysis buffer for measurement of luciferase activity
using the Dual-Luciferase Reporter Assay System (Promega). Fireﬂy
luciferase reporter activities were normalized according to the
Renilla luciferase controls. For detection of proteins from the
transfected cells, buffer X (50 mM Tris, pH 7.2, 270 mM NaCl,
0.5% Triton X-100, with freshly added 1 mM DTT and proteinase
inhibitors) was used to lyse a separate set of the transfection at
0.1 ml lysis buffer per well. The transiently expressed proteins
were detected with HRP-conjugated mouse anti-Flag and anti-HA
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the protein in each lane.
μCt analysis
Micro-computed tomography (μCT) scans of the whole body
and tibia of one month-old mice were performed using a Scanco
vivaCT 40, at 76 μm and 10.5 μm resolution, respectively. Serial
scans of whole body and tibia were reconstructed using machine
software.Results
Mesenchymal deletion of ESET Is associated with skeletal
malformation in mice
Our previous studies have suggested that ESET promoter is
constitutively active and ESET expression is likely, at least in part,
to be regulated at the protein level (Blackburn et al., 2003). We
have found that transient upregulation of ESET protein is most
prominent within the prehypertrophic regions in long bone
growth plates from E17.5, E18.5 embryos and newborn mice
(Fig. 1c and data not shown).
High levels of ESET protein in prehypertrophic chondrocytes
obviously implicate its involvement in skeletal development. Since
conventional knockout of ESET results in embryonic lethality around
the stage of implantation (Dodge et al., 2004), we decided to
investigate ESET functions through conditional knockout utilizing an
ESET allele in which exons 15 and 16 are ﬂanked by two loxP sites
(Fig. 1a). Cre-mediated deletion of these two exons will result in a
frame shift mutation that eliminates the entire bifurcated SET domain
(and hence the intrinsic H3–K9 methyltransferase activity) from ESETFig. 1. ESET gene structure, genotyping and transient upregulation in prehypertrophic
products for WT, ﬂoxed-ESET alleles and Cre transgene were shown along with the DN
antibody to show transient upregulation of ESET protein in prehypertrophic chondrocyprotein. To achieve conditional knockout of the ESET gene in speciﬁc
cells, we have chosen Prx1-Cre mice as the deleter strain since the
paired-related homeobox gene-1 (Prx1) limb enhancer is used to drive
mesenchymal cell-speciﬁc Cre expression in this mouse strain. At day
E9.5 in Prx1-Cre-positive embryos, Cre activity ﬁrst appears in the
forelimb mesenchyme, followed by appearance in the hind limb bud
within one day. By E16.5, Cre is uniformly active in the limb buds, the
interlimb ﬂank mesoderm and in a subset of craniofacial mesenchyme
while sparing the sclerotome mesoderm which gives rise to the
vertebrae and ribs (Logan et al., 2002).
Mating of ESET(exons 15&16)Flox/WT; Prx1-Cre with ESET(exons
15&16)Flox/WT or ESET(exons 15&16)Flox/Flox mice produced viable
newborn pups with various genotypes. We extracted DNA from
the tails where the Prx1-Cre transgene is not expressed, therefore
the size of PCR products in genotyping remains unchanged
(Fig. 1b). With the exception of ESET(exons 15&16)Flox/Flox; Prx1-
Cre mice, referred to as (exons 15&16)CKO/CKO mutants, all other
pups were similar in size and appearance. DNA analysis of more
than 100 embryos revealed that distribution of various possible
genotypes largely followed the Mendelian ratio. The (exons
15&16)CKO/CKO mutants are slightly smaller than wild-type litter-
mates but easily recognizable due to their characteristically
shortened forelimbs (Fig. 2a). We therefore focused on these
knockouts and used them to conﬁrm deletion of the ESET gene
in mesenchymal derived cells. As shown in Fig. 1c, transient
upregulation of ESET protein in prehypertrophic chondrocytes
found in wild-type tibia was indeed eliminated by conditional
knockout of the ESET gene in the mutant. The anti-ESET antibody used
in Fig. 1c was raised against residues 1–167 of mouse ESET protein and
can recognize any potentially truncated ESET protein missing its SET
domain. Since positive anti-ESET staining was almost non-existent in
the growth plates of (exons 15&16)CKO/CKO mutants, it appears that the
truncated ESET protein is not expressed or unstable, and deletion ofchondrocytes. (a) diagrams of ESET protein domains and the ﬂoxed allele. b, PCR
A size markers. c, proximal tibia in newborn mice was stained with an anti-ESET
tes in wild-type animal and absence of ESET staining in knockout littermate.
Fig. 2. Skeletal defects in ESET-deﬁcient newborn mice. (a) Photograph of wild-type and (exons 15&16)CKO/CKO mutant at birth. (b) Newborn skeletal preparations were
stained with alizarin red for comparison of bone elements. Double staining with alizarin red (bone) and alcian blue (cartilage) was carried out for the skull (c), rib cages (d),
forelimbs (e) and hind limbs (f). Genotypes of the embryos are indicated on the top.
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ESET protein when analyzed in chondrocytes.
In whole mount skeletons of newborn mice stained with
alizarin red (for bone), none of the skeletal elements were missing
from (exons 15&16)CKO/CKO animals (Fig. 2b). For a better compar-
ison between wild-type and mutants, additional newborn pups
were doubled stained with alizarin red and alcian blue (for
cartilage). Examination of the mutant skeletons revealed that
mesenchymal cell-speciﬁc deletion of the SET domain led to
signiﬁcant widening of the sagittal suture of the skull, delayed
ossiﬁcation of the sternum and a wider-than normal xiphoid
process, deformed scapulae and shortened digits and forelimbs
(Fig. 2c–e). While hind limbs of (exons 15&16)CKO/CKO newborn
pups did not show overt signs of gross defects, they were slightly
smaller than those of wild-type littermates (Fig. 2f).
Mesenchymal deletion of ESET causes disorganization of growth plate
chondrocytes and acceleration of chondrocyte hypertrophy
Flat bones of the skull are formed through intramembranous
ossiﬁcation whereby mesechymal stem cells directly differentiate
into osteoblasts. In contrast, formation of the long bones occurs
through endochondral ossiﬁcation, a process that requires growth
plates composed of chondrocytes at different stages of differentia-
tion. To investigate how deletion of ESET in mesenchymal cells
affects endochondral ossiﬁcation, we compared forelimb as well as
hindlimb growth plates between newborn wild-type and the
knockout pups. In growth plates within the humerus, wild-type
animals showed an orderly appearance of the resting zone at the
end, followed by the proliferative zone, the hypertrophic zone, the
calciﬁed cartilage zone and the ossiﬁcation zone. By comparison,
growth plates of (exons 15&16)CKO/CKO mutants were disorganized
(Fig. 3a). Even though the femurs of wild-type and (exons
15&16)CKO/CKO mice did not exhibit signiﬁcant external differencesat birth, histological staining of newborn femurs also revealed that
mesenchymal cell-speciﬁc deletion of the SET domain led to
disorganization of femoral growth plates (Fig. 3b).
To examine whether disorganization of growth plate chondro-
cytes is associated with increased cell death, we performed
immunohistostaining of newborn humerus for the presence of
active Caspase 3, a well-known marker for apoptosis (Janicke et al.,
1998). As shown in Fig. 3c, Caspase 3-positive cells were found
only among hypertrophic chondrocytes in wild-type humerus. In
contrast, Caspase 3-positive cells were more disorganized and
widely distributed in (exons 15&16)CKO/CKO humerus, suggesting
ectopic hypertrophy of chondrocytes in mice with mesenchymal-
speciﬁc deletion of ESET.
To further conﬁrm that ESET knockout results in disorganiza-
tion of growth plate and acceleration of chondrocyte hypertrophy,
we carried out immunohistostaining for type X collagen (a speciﬁc
marker for hypertrophic chondrocytes) in the developing long
bones in embryos and newborn mice. At embryonic stage E15.5,
as shown in Fig. 4a, type X collagen-positive cells were all conﬁned
to the hypertrophic zone and there was minimal difference
in chondrocyte hypertrophy between wild-type and (exons
15&16)CKO/CKO embryos. In wild-type newborn mice, type X
collagen-positive hypertrophic chondrocytes were still restricted
within the well-deﬁned hypertrophic zone, whereas type X
collagen-positive hypertrophic cells in (exons 15&16)CKO/CKO mice
were no longer conﬁned to a speciﬁc zone in the growth plate and
instead distributed more widely, even spreading into areas adja-
cent to the articular joint (Fig. 4b).
ESET Is essential to the formation of epiphyseal plate (physis) and
long bone growth
The observation that ESET knockout results in accelerated
chondrocyte hypertrophy and the fact that (exons 15&16)CKO/CKO
Fig. 3. Disorganization of growth plates in ESET-deﬁcient mice. (a) The humerus of newborn wild-type and (exons 15&16)CKO/CKO littermate were stained by H&E, and
representative regions are enlarged in the corresponding panels. (b) H&E staining of femurs from newborn wild-type and (exons 15&16 )CKO/CKO littermate, with typical areas
enlarged for better comparison. (c) Newborn distal humerus was stained by H&E, by an anti-active Caspase 3 antibody then mounted in DAPI medium to show apoptotic cells
as well as general morphology.
L. Yang et al. / Developmental Biology 380 (2013) 99–110 103pups are viable prompted us to investigate how ESET contributes
to postnatal development of the growth plate and long bone
formation. For the monitoring of growth plate development,
sections of distal femurs were stained with safranin O for detec-
tion of cartilage (red). As shown in Fig. 5a, the cartilage anlagen in
the distal femur of newborn knockout was already signiﬁcantly
reduced at birth than that of the wild-type littermate. By postnatal
day 10 when secondary ossiﬁcation centers are being developed in
wild-type animals, there were barely enough chondrocytes left
behind within the growth plates of knockout mice to sustain such
developments. In 14-day old wild-type animal, an epiphyseal plate
(physis) clearly separates primary ossiﬁcation center from the
secondary ossiﬁcation center, but the (exons 15&16)CKO/CKO animal
lacks such a cartilage plate. The shape of the distal femur in the
mutant mice has also been signiﬁcantly changed at this stage.
Epiphyseal plates are known to be responsible for long bone
growth, their absence in (exons 15&16)CKO/CKO mutants would bepredicted to impair postnatal development of the skeletal system.
Indeed, x-ray examination of ﬁve-week old (exons 15&16)CKO/CKO
skeletons conﬁrmed their long bone defects, especially the lack of
epiphyseal plates in themutant animals (Fig. 5b). These knockout mice
were signiﬁcantly smaller in size than their wild-type littermates and
had difﬁculty with locomotion (Fig. 5c and data not shown). Further
staining with alizarin red and alcian blue revealed severe defects in
both forelimbs and hind limbs of (exon 15&16)CKO/CKO mutants
(Fig. 5d). Since the Prx1-Cre deleter strain used in this study limits
deletion of the ESET gene only to certain mesenchymal cell-derived
tissues such as cartilage and bone, ESET expression in other cell
lineages is not affected. Thus, (exon 15&16)CKO/CKO mice can live up to
more than one year without signiﬁcant impairment to other vital
organs such as heart and lung.
To further investigate the effects of ESET knockout on postnatal
bone formation, we performed μCT scanning of skeletons from both
wild-type and (exons 15&16)CKO/CKO mutants. In one month-old
Fig. 4. Ectopic expression of type X collagen in ESET-deﬁcient mice. (a) Proximal humerus, distal femur and proximal tibia from E15.5 embryos were stained with an
antibody against type X collagen. Genotypes of the embryos are indicated on the top. (b) Growth plates in proximal humerus, distal femur and proximal tibia from newborn
mice were stained with the same antibody against type X collagen. Note that type X collagen-positive chondrocytes are limited to the hypertrophic zone in wild-type animal,
and diffusion of type X collagen-positive cells is observed throughout the growth plate in the knockout littermate.
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Fig. 5. Long bone defects and absence of epiphyseal plates in ESET-deﬁcient mice. (a) Safranin O staining of cartilage in the distal femur of mice at different stages of
postnatal development. (b) 5-week old wild-type and mutant mice were exposed to the same x-ray ﬁlm, with enlargement of the forelimb exposure. Arrows indicate
positions of epiphyseal plates at the ends of long bones. (c–d) Forelimbs and hind limbs from these 5-week old mice were stained with alcian blue and alizarin red to show
cartilage and long bone defects in the mutant.
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conﬁrmed the absence of epiphysesal plates (Fig. 6a and b). When
sagittal sections of the proximal tibia were analyzed, we noticed
severe defects in trabecular bone in (exons 15&16)CKO/CKO micewhen
compared with its wild-type littermates (Fig. 6c). When sections of
the proximal tibia were stained with an antibody against osteocalcin,
a noncollagenous protein secreted by mature osteoblasts into the
extracellular matrix of bone, defective formation of trabecular bone
in (exons 15&16)CKO/CKO mice was further conﬁrmed (Fig. 6d and e).
These ﬁndings indicate that ESET is critical to formation of trabe-
cular bone during post-natal development.
ESET physically interacts with Runx2-HDAC4 and functionally
represses Runx2-mediated reporter gene transactivation
ESET protein is transiently upregulated in prehypertrophic
chondrocytes and partially overlaps with the expression of both
Runx2 and HDAC4. Runx2 is a Runt domain-containing transcrip-
tion factor that promotes chondrocyte hypertrophy and bone
formation (Komori et al., 1997; Otto et al., 1997). On the other
hand, HDAC4 inhibits chondrocyte hypertrophy through interact-
ing with and repressing the activity of Runx2 (Vega et al., 2004).
To investigate whether ESET protein physically interacts withRunx2-HDAC4, we co-transfected 293 T cells with plasmids
expressing Flag-epitope tagged ESET and HA-epitope tagged
Runx2. We have noticed that 293 T cells express high levels of
endogenous HDAC4 for potential association with Flag-ESET and/
or HA-Runx2. In anti-HA-Runx2 immunoprecipates prepared with
the transfected 293 T lysate, we detected the presence of both
Flag-ESET and endogenous HDAC4. In reciprocal immunoprecipi-
tation with an anti-Flag antibody, we detected HA-Runx2 but
failed to conﬁrm the presence of HDAC4 under these experimental
conditions. However, we did detect both Flag-ESET and HA-Runx2
from the anti-HDAC4 immunoprecipitates (Fig. 7a), demonstrating
that a subset of the ESET protein forms a multi-protein complex
with both Runx2 and HDAC4.
To investigate whether ESET interaction with Runx2 results in
transcriptional repression of Runx2 target genes, we transfected
COS-7 cells with the murine osteocalcin gene 2 (mOG2)-Luc
reporter plus Runx2 and ESET expression plasmids. The mOG2
promoter is a well characterized target of Runt proteins and
contains three binding sites for Runx2 (Schroeder et al., 2004).
Co-transfection with Runx2 plasmid indeed activated the osteo-
calcin promoter by more than 4-fold in the luciferase assay
(Fig. 7b). When Runx2 and ESET plasmids were co-transfected
into COS-7 cells, Runx2 activation of this mOG2 promoter was
Fig. 6. Trabecular bone defects in ESET-deﬁcient adult mice. (a) whole skeletal μCT scan of one month-old wild-type and (exons 15&16)CKO/CKO littermate. Arrow indicates the
incomplete fontanel closure in the knockout skull. (b), 3-D reconstruction of one month-old tibia from wild-type and knockout mice. Position of the epiphyseal plate is
indicated by an arrow. c, longitudinal view through the mid-point of the tibia. (d–e) Decalciﬁed sections of proximal tibia from one month-old mice were stained by H&E to
show general cell morphology, and by anti-osteocalcin to show differences in trabecular bone. Note absence of the epiphyseal plate in the knockout animal. Genotypes are
indicated on the top.
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Runx2 activity by ESET is mediated through its intrinsic histone
methyltransferase activity, we co-transfected HA-Runx2 with Flag-
ESET(C1243T) mutant that changes the highly conserved cysteine
at 1243 to threonine within the SET domain to inactivate its
histone methyltransferase activity (Yang et al., 2002). As seen in
Fig. 7b, we found that the ESET(C1243T) mutant failed to repress
Runx2-meidated transactivation of the osteocalcin promoter. Since
ESET protein interacts with both Runx2 and HDAC4, the possibility
that ESET repression of Runx2 activity may also require interaction
with HDAC4 or other histone dacetylases was further tested. For
this, the transfected cells were treated with trichostatin A (an
HDAC inhibitor) to eliminate contribution by the histone deacety-
lase(s). Interestingly, trichostatin A treatment reversed repression
of Runx2 activity by ESET, demonstrating that repression of
Runx2-mediated transactivation by ESET requires both its intrinsic
H3–K9 methyltransferase activity as well as its associated HDAC
activity.
ESET knockout disrupts Ihh expression in growth plate chondrocytes
The acceleration of chondrocyte hypertrophy and a severe lack
of trabecular bone seen in (exons 15&16)CKO/CKO mice prompted a
closer comparison with skeletal phenotypes previously reported
for other key regulators of skeletal development. It is noticed that
mesenchymal deletion of ESET and conditional knockout of Ihh in
postnatal chondrocytes share many similar skeletal defects
(Maeda et al., 2007). These include ectopic hypertrophic chon-
drocytes in the growth plate, premature fusion of epiphyseal
plates of various endochondral bones, and defects in trabecular
bone formation. To investigate whether mesenchymal deletion of
ESET inﬂuences expression of the Ihh gene in prehypertrophic andearly hypertrophic chondrocytes, we carried out immunohistos-
taining of newborn tibia with a rabbit polyclonal anti-Ihh anti-
body. As shown in Fig. 8a, highest level of Ihh expression in the
wild-type growth plate is indeed detected in pre- and early
hypertrophic chondrocytes. Within the comparable region of
growth plate in the mutant (exons 15&16)CKO/CKO littermates,
however, Ihh protein level is signiﬁcantly reduced and its expres-
sion pattern severely interrupted (Fig. 8b).Discussion
In this manuscript we have established that the H3–K9 methyl-
transferase ESET plays an essential role during the differentiation
of growth plate chondrocytes, and conditional deletion of the ESET
gene results in an untimely acceleration of chondrocyte hypertro-
phy and impairment of endochondral bone formation. It should be
pointed out that the observed phenotype in (exons 15&16)CKO/CKO
mutants is 100% penetrant. Our ﬁndings that (1) ESET interacts
with both Runx2 and HDAC4, (2) that ESET inhibits Runx2 target
genes through its intrinsic H3–K9 methyltransferase activity and
its associated HDAC activity, and (3) that mesenchymal deletion of
ESET in mice generates a phenotype closely resembling the
phenotype observed in HDAC4-null embryos all point to the
possibility that an ESET-Runx2-HDAC4 core complex in the pre-
hypertrophic zone functions as the gate-keeper for an orderly
entry of prehypertrophic chondrocytes into terminal differentia-
tion. Disruption in any one component of this core protein
complex may functionally inactivate the entire complex and cause
an abnormal ‘histone code’, leading to either delayed or acceler-
ated chondrocyte hypertrophy.
Fig. 7. Physical and functional interactions of ESET with Runx2 and HDAC4. (a) Nuclear extract from 293 T cells that co-express Flag-ESET and HA-Runx2 were incubated
with a mouse monoclonal anti-HA, a mouse monoclonal anti-Flag, normal mouse IgG, or a mouse monoclonal anti-HDAC4. The immunoprecipitates were then blotted with
HRP-conjugated anti-Flag, anti-HA or a goat anti-HDAC4 for detection of the co-immunoprecipitated proteins. (b) COS-7 cells were co-transfected with the mOG2-Luc ﬁreﬂy
luciferase reporter plus Runx2 and ESET plasmids, and trichostatin A was added 24 h post transfection. Total amount of DNA in each transfection was kept constant by the
addition of empty vector DNA, and ﬁreﬂy luciferase activities were normalized according to the Renilla luciferase controls. Shown are results from three independent
experiments. Western blotting of lysates from a typical experiment was carried out to show comparable protein expression in each sample.
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Fig. 8. Disruption of Ihh expression in ESET deﬁcient mice. (a) Sections of proximal tibia from wild-type newborn mice were stained by H&E to show cell morphology, by an
anti-Ihh antibody to show Ihh protein expression in pre- and early hypertrophic chondrocytes, by DAPI to show distribution of nuclei within the growth plate. The anti-Ihh
staining was merged with the DAPI image for better localization of Ihh-positive cells. (b) Sections of proximal tibia from newborn (exon 15&16)CKO/CKO mutant were stained
by H&E, anti-Ihh and DAPI to show decreased Ihh expression in the growth plate.
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enzymes such as HDAC3 (Schroeder et al., 2004), HDAC7 (Jensen
et al., 2008), and Suv39h1 (Tandon et al., 2012), and a subset of
ESET is found together with Suv39h-G9a-GLP (Fritsch et al., 2010),
additional epigenetic enzymes may be associated with the ESET-
Runx2-HDAC4 core complex in the control of chondrocyte
hypertrophy.
Even though Runx2 and HDAC4 are well known for their critical
roles in the control of chondrocyte hypertrophy, Runx2−/− or
HDAC4−/− animals are not viable at birth. As the (exon
15&16)CKO/CKO mice are viable at birth and live up to one yearwithout obvious defects in other organ systems, these mice have
offered us a unique opportunity to further study bone formation
when growth plate chondrocytes undergo accelerated hypertro-
phy. Indeed, we have found that ESET is critical to postnatal
skeletal development, and premature hypertrophic differentiation
in (exon 15&16)CKO/CKO animals depletes chondrocytes that normally
form the epiphyseal plates. Since the epiphyseal plate is responsible
for long bone growth during childhood, it is tempting to speculate
that ESET histone methyltransferase is intimately involved in the
closure of epiphyseal plates at the end of puberty, and that ESET
itself could be regulated by sex hormones or other growth hormones
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length in each individual.
For this study we used the Prx1-Cre strain to delete the ﬂoxed ESET
gene in mesenchymal cells and have focused on ESET regulation of
chondrocyte hypertrophy and its inﬂuence on long bone growth. Even
though it is evident that accelerated chondrocyte hypertrophy is
responsible for the lack of epiphyseal plate and long bone growth in
ESET-null mice, the possibility does exist that conditional knockout of
the ESET gene could also impair differentiation of other mesenchymal
derived cell types, for example, the differentiation into osteoblasts and
the formation of intramembranous bone. As seen in Fig. 2c and Fig. 6a,
delayed closure of the cranial suture was indeed evident in the
conditional ESET knockout mice. This defect in osteoblast differentia-
tion could again be explained by ESET interaction with Runx2: while
Runx2 is essential to osteoblast differentiation during embryogenesis
(Komori et al., 1997; Otto et al., 1997), transgenic over-expression of
Runx2 in postnatal mice actually inhibits osteoblast maturation and
leads to osteopenia (Geoffroy et al., 2002; Liu et al., 2001). Since a
precisely controlled level of Runx2 activity is critical to normal bone
formation and maintenance, a likely scenario is that the trans-
activating ability of Runx2 is normally kept in balance by ESET histone
methyltransferase and by its associated histone modiﬁcation enzymes.
In ESET-deﬁcient mesenchymal cells, Runx2 is no longer under such
precise control and can activate an aberrant gene expression program
that is detrimental to differentiation of mesenchymal stem cells into
functional osteoblasts.
It is interesting but not surprising that speciﬁc ESET knockout
in mesenchymal cells share some common features with
chondrocyte-speciﬁc postnatal Ihh knockout (Maeda et al.,
2007). Both ESET and Ihh knockout mice exhibited premature
hypertrophy of chondrocytes, failure of long bone growth due to a
lack of epiphyseal plates, and continuous loss of trabecular bone.
Ihh is normally expressed by pre- and early hypertrophic chon-
drocytes in the growth plate to promote osteoblast differentiation
(St-Jacques et al., 1999), and mouse embryos deﬁcient in Ihh
completely lack osteoblasts within the endochondral skeleton.
Since mesenchymal knockout of ESET is associated with a sig-
niﬁcant reduction of Ihh protein in growth plate chondrocytes,
disruption of Ihh expression undoubtedly contributes to skeletal
phenotype described for (exons 15&16)CKO/CKO mice in this study.
However, it should be pointed out that deregulation of Ihh
expression cannot account for all the defects found in (exons
15&16)CKO/CKO mice. For example, while Ihh knockout did not
affect intramembranous ossiﬁcation, ESET knockout did cause
intramembranous bone defects such as incomplete closure of
cranial sutures even in one month-old (exons 15&16)CKO/CKO
(Fig. 6a). Additionally, trabecular bone loss is also more severe in
(exons 15&16)CKO/CKO mice than seen in mice with chondrocyte-
speciﬁc postnatal Ihh knockout (Maeda et al., 2007). These
differences are possible since ESET knockout is targeted in
mesenchymal cells that differentiate into both chondrocytes and
osteoblasts, and the postnatal Ihh deletion occurred only in
chondrocytes. Also, ESET knockout is expected to increase
Runx2-mediated gene transcription in both chondrocytes and
osteoblasts, whereas it is unclear how postnatal Ihh knockout in
chondrocytes affects Runx2 and its target genes in osteoblasts.
It has been reported recently that malignant melanomas express
much higher levels of ESET protein than normal melanocytes, and that
human naevi over-expressing ESET are more likely to undergo
oncogenic progression than naevi expressing basal levels of ESET
protein (Ceol et al., 2011). Additionally, siRNA knockdown of ESET in
embryonic stem cells is associated with the loss of pluripotency (Yeap
et al., 2009; Yuan et al., 2009). Our ﬁndings together with these
reports link high levels of ESET expression in a given cell population to
a less mature differentiation status, supporting the role of ESET as a
key regulator in cellular decision to enter into terminal differentiation.Acknowledgments
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